Combination therapy of infliximab and thiopurines, but not monotherapy with infliximab or vedolizumab, is associated with attenuated IgA and neutralisation responses to SARS-CoV-2 in inflammatory bowel disease.
Gut
; 71(9): 1919-1922, 2022 09.
Article
in English
| MEDLINE | ID: covidwho-1575894
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Inflammatory Bowel Diseases
/
COVID-19
Limits:
Humans
Language:
English
Journal:
Gut
Year:
2022
Document Type:
Article
Affiliation country:
Gutjnl-2021-326312
Similar
MEDLINE
...
LILACS
LIS